Form 8-K - Current report:
SEC Accession No. 0001104659-25-111484
Filing Date
2025-11-13
Accepted
2025-11-13 17:13:40
Documents
138
Period of Report
2025-11-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20251113x8k.htm   iXBRL 8-K 264820
2 EX-23.1 chrs-20251113xex23d1.htm EX-23.1 9040
3 EX-99.1 chrs-20251113xex99d1.htm   iXBRL EX-99.1 2423604
  Complete submission text file 0001104659-25-111484.txt   16454992

Data Files

Seq Description Document Type Size
4 EX-101.SCH chrs-20251113.xsd EX-101.SCH 135842
5 EX-101.CAL chrs-20251113_cal.xml EX-101.CAL 148527
6 EX-101.DEF chrs-20251113_def.xml EX-101.DEF 620874
7 EX-101.LAB chrs-20251113_lab.xml EX-101.LAB 1064740
8 EX-101.PRE chrs-20251113_pre.xml EX-101.PRE 962532
141 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20251113x8k_htm.xml XML 3238738
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus Oncology, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 251479737
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)